Pacer Advisors Inc. Purchases 11,324 Shares of Doximity, Inc. (NASDAQ:DOCS)

Pacer Advisors Inc. boosted its stake in shares of Doximity, Inc. (NASDAQ:DOCSFree Report) by 78.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,802 shares of the company’s stock after acquiring an additional 11,324 shares during the quarter. Pacer Advisors Inc.’s holdings in Doximity were worth $723,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of DOCS. Bank of New York Mellon Corp raised its stake in Doximity by 60.6% during the first quarter. Bank of New York Mellon Corp now owns 172,855 shares of the company’s stock worth $9,004,000 after acquiring an additional 65,196 shares in the last quarter. US Bancorp DE raised its stake in Doximity by 325.4% during the first quarter. US Bancorp DE now owns 2,646 shares of the company’s stock worth $138,000 after acquiring an additional 2,024 shares in the last quarter. Cambridge Investment Research Advisors Inc. raised its stake in Doximity by 417.4% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 21,099 shares of the company’s stock worth $1,099,000 after acquiring an additional 17,021 shares in the last quarter. Natixis Advisors L.P. acquired a new position in Doximity during the first quarter worth $983,000. Finally, BlackRock Inc. raised its stake in Doximity by 53.6% during the first quarter. BlackRock Inc. now owns 2,052,183 shares of the company’s stock worth $106,898,000 after acquiring an additional 716,547 shares in the last quarter. 87.19% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, Director Kira Scherer Wampler sold 2,500 shares of Doximity stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $26.97, for a total transaction of $67,425.00. Following the transaction, the director now owns 10,258 shares in the company, valued at approximately $276,658.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 39.40% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. Evercore ISI restated an “in-line” rating and issued a $30.00 target price on shares of Doximity in a research note on Tuesday. Barclays initiated coverage on Doximity in a research note on Wednesday, January 3rd. They issued an “equal weight” rating and a $31.00 target price for the company. Bank of America lifted their price objective on Doximity from $29.00 to $32.00 and gave the stock a “neutral” rating in a research report on Tuesday, January 23rd. Truist Financial lifted their price objective on Doximity from $28.00 to $29.00 and gave the stock a “hold” rating in a research report on Friday, February 9th. Finally, JPMorgan Chase & Co. lifted their price objective on Doximity from $22.00 to $25.00 and gave the stock an “underweight” rating in a research report on Friday, March 15th. Two investment analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Hold” and a consensus price target of $28.82.

Check Out Our Latest Stock Report on DOCS

Doximity Price Performance

NASDAQ:DOCS opened at $25.70 on Thursday. Doximity, Inc. has a fifty-two week low of $19.71 and a fifty-two week high of $37.10. The stock has a market capitalization of $4.79 billion, a PE ratio of 38.94, a price-to-earnings-growth ratio of 3.32 and a beta of 1.17. The business’s 50-day simple moving average is $28.12 and its 200-day simple moving average is $25.71.

Doximity (NASDAQ:DOCSGet Free Report) last released its quarterly earnings data on Thursday, February 8th. The company reported $0.25 earnings per share for the quarter, beating the consensus estimate of $0.19 by $0.06. Doximity had a return on equity of 16.08% and a net margin of 29.39%. The business had revenue of $135.28 million for the quarter, compared to analysts’ expectations of $127.46 million. On average, research analysts expect that Doximity, Inc. will post 0.72 earnings per share for the current year.

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Read More

Want to see what other hedge funds are holding DOCS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Doximity, Inc. (NASDAQ:DOCSFree Report).

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.